Singapore was one of the first countries hit by the coronavirus, COVID-19. The city state’s early response, which included cash incentives to work from home, chatbots and a national Whatsapp channel to educate and inform citizens, has earned praise from the World Health Organization and in scientific research.
While investors are expected to become more cautious in the coming months, in March, fundings continued to pour in for Southeast Asian startup ecosystem. The e27 content team noticed that there seemed to be a bigger number of seed-stage funding rounds being announced during the month, as opposed to Series A.
“Prevention is better than cure” is the mantra spurring some of this year’s 30 Under 30 Asia listees in the Healthcare & Science category to start their health-tech ventures. Stroke is the world’s second-leading cause of death after heart disease, a statistic that inspired Milad Mohammadzadeh and Sadaf Monajemi in 2017 to launch See-Mode Technologies to better predict the risk of strokes.
Singapore-based logistics startup Moovaz has secured an undisclosed Series A investment from government-owned Deep Tech investor SGInnovate, and Supply Chain Angels (SCAngels).
“Besides the need for ‘patient’ capital, there are various unique technical, structural and cultural barriers that these startups have to overcome. It takes years, not just a few deals, to go through the cycle to get the real experience and make the right judgement calls.” — said Hsien-Hui Tong, Head of Venture Investing at SGInnovate
Cybersecurity startup Right-Hand has raised US$1 million in a seed funding round led by Singapore-based early-stage venture capital fund Atlas Ventures, it said on Thursday. Other investors include Singapore government-owned Deep Tech investor SGInnovate, and tech company builder Entrepreneur First.